Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Symptomatic infection with Blastocystis sp. subtype 8 successfully treated with trimethoprim-sulfamethoxazole.

× No keyword cloud information.

19 in total

1. Blastocystis sp. subtype 4 is common in Danish Blastocystis-positive patients presenting with acute diarrhea.

Authors: Christen Rune Stensvold; Dorte Bang Christiansen; Katharina Elisabeth Pribil Olsen; Henrik Vedel Nielsen
Journal: Am J Trop Med Hyg Date: 2011-06 Impact factor: 2.345

2. A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities.

Authors: Haris Mirza; Joshua D W Teo; Jacqui Upcroft; Kevin S W Tan
Journal: Antimicrob Agents Chemother Date: 2010-11-22 Impact factor: 5.191

3. Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment.

Authors: Kalyani Raman; Suresh Kumar; Tan Tian Chye
Journal: Parasitol Res Date: 2015-10-20 Impact factor: 2.289

4. Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.

Authors: Arutchelvan Rajamanikam; Suresh Kumar; Chandramathi Samudi; Madhav Kudva
Journal: Parasitol Res Date: 2018-06-05 Impact factor: 2.289

5. The hidden impact of different Blastocystis genotypes on C-3 and IgE serum levels: a matter of debate in asthmatic Egyptian children.

Authors: Enas A El Saftawy; Noha M Amin; Dina H Hamed; Aly Elkazazz; Sherihan Adel
Journal: J Parasit Dis Date: 2019-03-30

6. Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis.

Authors: T Roberts; D Stark; J Harkness; J Ellis
Journal: Eur J Clin Microbiol Infect Dis Date: 2012-09-21 Impact factor: 3.267

Symptomatic infection with Blastocystis sp. subtype 8 successfully treated with trimethoprim-sulfamethoxazole.

1. Blastocystis sp. subtype 4 is common in Danish Blastocystis-positive patients presenting with acute diarrhea.

2. A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities.

3. Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment.

4. Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.

5. The hidden impact of different Blastocystis genotypes on C-3 and IgE serum levels: a matter of debate in asthmatic Egyptian children.

6. Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis.

7. In Vitro Antimicrobial Susceptibility Patterns of Blastocystis.

Review 8. New insights on classification, identification, and clinical relevance of Blastocystis spp.

9. Changing trends in intestinal parasitic infections among long-term-residents and settled immigrants in Qatar.

Review 10. Blastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosis.